// src/data/bloodData.js

// Main Sponsor Category
const mainSponsor = [
  {
    category: "Main Sponsor",
    items: [
      {
        name: "Grifols",
        img: "/img/Grifols.png",
        description:
          "A global healthcare company specializing in plasma-derived medicines, transfusion diagnostics, and hospital pharmacy solutions. Grifols is a leader in advancing plasma science and biopharmaceutical therapies, with a strong focus on oncology, immunology, and the development of innovative treatments derived from blood and plasma.",
      },
    ],
  },
];

// Supporting Stakeholders Category
const supportingStakeholders = [
  {
    category: "Supporting Stakeholders",
    subcategories: [
      {
        name: "Startups",
        items: [
          {
            name: "Flomics",
            description:
              "Specializes in bioinformatics and molecular profiling to enable early detection and precision treatment of blood-related cancers, particularly in oncology. Their platform aids in identifying specific biomarkers for personalized blood cancer therapies.",
          },
          {
            name: "Loop Diagnostics",
            description:
              "A diagnostic startup focusing on the early detection and monitoring of blood disorders, including hematological malignancies, through innovative, non-invasive blood tests.",
          },
          {
            name: "NIVD",
            description:
              "Developing technologies for the diagnosis and monitoring of immunological and blood-related diseases, including advanced plasma diagnostics and testing solutions.",
          },
          {
            name: "MiWEndo Solutions",
            description:
              "A health tech company focusing on early diagnosis and treatment of blood cancers and other related disorders, utilizing a unique combination of imaging and blood-based biomarkers.",
          },
          {
            name: "Sycai",
            description:
              "A startup offering AI-driven platforms to enhance the prediction, diagnosis, and treatment of blood-related diseases, including hematological malignancies and immunological disorders.",
          },
          {
            name: "IntelVasc Inc.",
            description:
              "Specializes in advanced diagnostics and medical devices that utilize blood biomarkers to diagnose cardiovascular and blood-related diseases at an early stage.",
          },
          {
            name: "IOMED",
            description:
              "A health technology company focused on medical data integration to improve treatment strategies for blood cancers and immunological disorders, using advanced data analytics to personalize patient care.",
          },
          {
            name: "Doctomatic",
            description:
              "An AI-driven health platform focusing on personalized medicine for blood disorders, offering diagnostic solutions for blood cancers, immunology, and transfusion-related diseases.",
          },
          {
            name: "DevsHealth",
            description:
              "A healthtech company dedicated to providing data-driven insights for the management of blood and plasma-based medical treatments, with an emphasis on optimizing blood donation processes and improving patient outcomes in hematology.",
          },
        ],
      },
      {
        name: "Pharmaceutical Companies",
        items: [
          {
            name: "B. Braun",
            description:
              "A global medical and pharmaceutical company, focusing on innovative solutions in blood-related treatments, including transfusion medicine, plasma-derived therapies, and oncology.",
          },
          {
            name: "Johnson & Johnson",
            description:
              "A leading pharmaceutical company with a wide range of therapies, including treatments for blood cancers, immunology, and plasma-derived biopharmaceuticals.",
          },
          {
            name: "Novo Nordisk",
            description:
              "A global healthcare leader focusing on treatments for blood-related conditions, such as hemophilia and diabetes, and advancing immunology therapies for autoimmune diseases.",
          },
        ],
      },
      {
        name: "Health Institutions",
        items: [
          {
            name: "Hospital del Mar",
            description:
              "A major hospital in Barcelona, specializing in the treatment of blood-related diseases, including hematological cancers and transfusion therapies.",
          },
          {
            name: "Vall d’Hebron",
            description:
              "A leading research hospital in Barcelona, renowned for its expertise in hematology, immunology, and plasma-derived treatments for blood cancers and immune disorders.",
          },
          {
            name: "Hospitales Quirón Salud",
            description:
              "A network of hospitals that focuses on advanced treatments for blood and plasma-related disorders, including oncology and immunology care.",
          },
        ],
      },
      {
        name: "Research Institutions",
        items: [
          {
            name: "Bioinformatics Barcelona",
            description:
              "A research institute specializing in bioinformatics and computational tools for the study and treatment of blood diseases, including precision oncology and immunology.",
          },
          {
            name: "Institut de Recerca Barcelona",
            description:
              "A leading research institute in Barcelona, conducting cutting-edge studies on blood cancers, plasma-derived treatments, and immunological disorders.",
          },
          {
            name: "Catalan Institute of Nanoscience and Nanotechnology",
            description:
              "An institute focused on advancing nanotechnology to improve blood disease diagnostics and treatment, particularly in oncology and immunology.",
          },
          {
            name: "Spanish National Research Council (CSIC)",
            description:
              "A leading Spanish research institution conducting research into blood-related diseases, with a focus on immunology, blood cancers, and plasma science.",
          },
        ],
      },
      {
        name: "Investors",
        items: [
          {
            name: "Ysios Capital",
            description:
              "A venture capital firm focused on investing in innovative healthtech companies, particularly those developing novel treatments for blood diseases, including plasma-derived therapies and blood cancer treatments.",
          },
          {
            name: "Sabadell Venture Capital",
            description:
              "An investor specializing in early-stage healthtech startups, supporting companies focused on blood-related therapies, oncology, and immunology.",
          },
          {
            name: "Nauta Capital",
            description:
              "A venture capital firm supporting innovative startups in healthtech, with an interest in blood-related diagnostics, immunology, and plasma therapies.",
          },
        ],
      },
    ],
  },
];

// Panel Discussion Category
const panelDiscussion = [
  {
    category: "Panel Discussion",
    title:
      "Leveraging Connectivity for Better Patient Outcomes in Blood and Plasma-Derived Treatments",
    description:
      "This panel will explore how connectivity and seamless data integration can improve patient care in the field of blood-related diseases. Experts will discuss the biological connectivity within the circulatory system, advancements in plasma science, and how data-sharing across platforms can enhance the management of conditions like blood cancers, immunological disorders, and hemophilia. The discussion will focus on improving access to treatments and fostering collaboration among healthcare professionals to create a more inclusive and effective healthcare ecosystem.",
    panelists: [
      "Mariona Sanz, Head of Innovation, Barcelona Supercomputing Center",
      "Josep Sanfeliu, Managing Partner, Asabys",
      "Bibiana Berenguer, Head of Innovation, Novartis",
      "Mar Massó, Innovation Senior Manager, Grifols",
    ],
  },
];

// Open Innovation Challenges Category
const openInnovationChallenges = [
  {
    category: "Open Innovation Challenges",
    items: [
      {
        name: "Diabetes Connectivity Challenge: EHR Integration, Interoperability, and Behavioral Engagement",
        challengeOwner: "Sanofi",
        description:
          "This challenge aims to improve patient care by integrating connected devices into electronic health records (EHR), ensuring seamless data transfer and interoperability. It also focuses on enhancing patient engagement through behavioral techniques and gamification to encourage consistent use of diabetes management tools, which has potential applications in blood sugar management and other blood-related treatments.",
      },
      {
        name: "People-Centered Technology: Adaptability and Inclusion, Personalized Social Prescription",
        challengeOwner: "Xarxa Assistencial Universitària de Manresa",
        description:
          "This challenge seeks tech companies to develop customized digital avatars that represent the experiences of individuals with health conditions, including those with blood-related disorders. These avatars will help healthcare professionals, educators, and family members understand patient needs, simulate treatment scenarios, and improve the quality of life for individuals with blood cancers or immunological conditions.",
      },
    ],
    description:
      "Think you have a solution? Innovate and be part of the revolution!",
  },
];

// Export all categories in an object
export const bloodCategories = {
  mainSponsor,
  supportingStakeholders,
  panelDiscussion,
  openInnovationChallenges,
};
